You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Welcome to the GSK Respiratory knowledge base

The respiratory knowledge base hosts in-depth videos on the benefits of the Ellipta device and how the Ellipta portfolio can be used to manage your patients with COPD.

(Links to the prescribing information for our respiratory products can be found at the bottom of this page).

Select from the videos below to get started.

Ellipta for COPD (Chronic Obstructive Pulmonary Disease)

Personalising treatment for your patients

Salford Lung Study - study design and results

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/David-Leather-SLS-study-design-and-results.mp4

Dr David Leather discusses the study design and results of the Salford Lung Study in COPD. Video length = 5.16 mins.

Exacerbations and pneumonia in patients with COPD: balancing the risks and benefits of ICS

Dr Neil Martin, Medical Expert Lead at GlaxoSmithKline highlights the significant impact exacerbations have on the lives of patients with COPD and the role of ICS/LABAs in reducing exacerbation frequency. Video length = 7.57 mins.

Ellipta for asthma

Delivering excellence in asthma management: Complacency in asthma can kill (NRAD)

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/Neil-Martin-Delivering-excellence-in-asthma-mgt-NRAD.mp4

Dr Neil Martin, Medical Expert Lead at GlaxoSmithKline highlights the importance of good asthma management by discussing NRAD and the Asthma UK prescribing report. Video length = 5.50 mins.

Inhaler device training

The Ellipta device

Helping patients with asthma and COPD receive the full benefit of their medication

Why Ellipta

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/Why-Ellipta.mp4

Benefits of an easy to use device on adherence and patient outcomes. Video length = 5.28 mins.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Anoro, Incruse, Ellipta, Nucala, Relvar and Seretide are registered trademarks of the GlaxoSmithKline group of companies

R.L. Last updated: February 2017. UK/RESP/0485/15a(4)